Coronavirus

>

Latest News

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment / Image credit: ©Mauro Rodrigues/AdobeStock
Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment

January 20th 2025

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose / image credit: ©New Africa/AdobeStock
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose

December 18th 2024

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose / image credit: ©New Africa/AdobeStock
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose

November 29th 2024

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals image credit Richard S Saver, JD, University of North Carolina School of law
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals

November 13th 2024

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine / Image credit: ©Kateryna_Kon/AdobeStock
FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine

November 12th 2024

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.